Teva ADR: income coincided, pribylya overtook expectations in Q3

To Add/clean TEVA of-1,03% from a portfolio to Add in the Position Add a Position list it is successfully added: %2B to Add other position to Close Investing.com - Teva Pharmaceutical Industries Ltd ADR (NYSE: TEVA) issued on Wednesday the report with results in the third quarter which coincided from analysts. The indicator of the income exceeded forecasts. Company declared an earning per share of $0,60, the income made of $3,9B. The analysts interrogated by Investing.com, assumed in forecasts that the earning per share will make $0,60, and the total income will make of $3,72B Teva Pharmaceutical Industries Ltd ADR follows the general trend of companies sectors...